Hautarztpraxis Dres. Leitz
Stuttgart, Germany
Dermatologist in Stuttgart, Baden-Württemberg
Marienstraße 1, 70178 Stuttgart
About Hautarztpraxis Dres. Leitz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Pfizer
2
Blueberry Therapeutics
1
Janssen Research & Development, LLC
1
Janssen-Cilag G.m.b.H
1
LEO Pharma
1
Clinical Trials at Hautarztpraxis Dres. Leitz
During the past decade, Hautarztpraxis Dres. Leitz conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
2017-11-03
2019-03-21
Completed
210
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
2018-05-15
2023-05-02
Active, not recruiting
463
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
2018-07-11
2025-06-02
Recruiting
125
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
2018-06-26
2020-06-03
Completed
1,484
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
2018-06-11
2020-10-07
Completed
1,235
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
2019-02-08
2025-01-30
Active, not recruiting
880
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
2021-03-22
2023-07-01
Active, not recruiting
111
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hautarztpraxis Dres. Leitz" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Blueberry Therapeutics" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag G.m.b.H"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hautarztpraxis Dres. Leitz"
#1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hautarztpraxis Dres. Leitz
According to Clinical.Site data, the most researched conditions in "Hautarztpraxis Dres. Leitz" are
"Psoriasis" (3 trials), "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis" (1 trials) and "Distal Subungual Onychomycosis" (1 trials). Many other conditions were trialed in "Hautarztpraxis Dres. Leitz" in a lesser frequency.
Clinical Trials Intervention Types at Hautarztpraxis Dres. Leitz
Most popular intervention types in "Hautarztpraxis Dres. Leitz" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "BB2603-1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hautarztpraxis Dres. Leitz
The vast majority of trials in "Hautarztpraxis Dres. Leitz" are
8 trials for "All" genders.
Clinical Trials Status at Hautarztpraxis Dres. Leitz
Currently, there are NaN active trials in "Hautarztpraxis Dres. Leitz".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hautarztpraxis Dres. Leitz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hautarztpraxis Dres. Leitz, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".